These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11039360)

  • 1. Abciximab rescue in acute carotid stent thrombosis.
    Tong FC; Cloft HJ; Joseph GJ; Samuels OB; Dion JE
    AJNR Am J Neuroradiol; 2000 Oct; 21(9):1750-2. PubMed ID: 11039360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abciximab for the treatment of acute distal embolization associated with internal carotid artery angioplasty.
    Kittusamy PK; Koenigsberg RA; McCormick DJ
    Catheter Cardiovasc Interv; 2001 Oct; 54(2):221-33. PubMed ID: 11590690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience.
    Qureshi AI; Suri MF; Khan J; Fessler RD; Guterman LR; Hopkins LN
    Neurosurgery; 2000 Jun; 46(6):1316-24; discussion 1324-5. PubMed ID: 10834637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab.
    Qureshi AI; Suri MF; Ali Z; Kim SH; Lanzino G; Fessler RD; Ringer AJ; Guterman LR; Hopkins LN
    Neurosurgery; 2002 Mar; 50(3):466-73; discussion 473-5. PubMed ID: 11841713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results.
    Schneiderman J; Morag B; Gerniak A; Rimon U; Varon D; Seligsohn U; Shotan A; Adar R
    J Endovasc Ther; 2000 Aug; 7(4):263-72. PubMed ID: 10958289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in the inhibition of neointimal hyperplasia by abciximab in a rat model of balloon angioplasty.
    Wu CH; Chen YC; Hsiao G; Lin CH; Liu CM; Sheu JR
    Thromb Res; 2001 Feb; 101(3):127-38. PubMed ID: 11228336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.
    Marso SP; Lincoff AM; Ellis SG; Bhatt DL; Tanguay JF; Kleiman NS; Hammoud T; Booth JE; Sapp SK; Topol EJ
    Circulation; 1999 Dec 21-28; 100(25):2477-84. PubMed ID: 10604884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenting with intravenous abciximab infusion for the treatment of left main coronary artery thrombosis during coronary angioplasty.
    Choi D; Jang Y; Lee BK; Choi SH; Byun KH; Shim WH; Cho SY
    J Invasive Cardiol; 2001 Feb; 13(2):107-10. PubMed ID: 11176018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute thrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab.
    Schlaifer JD; Horgan W; Malkowski MJ
    Clin Cardiol; 2001 Dec; 24(12):788. PubMed ID: 11768744
    [No Abstract]   [Full Text] [Related]  

  • 12. Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
    Schühlen H; Kastrati A; Mehilli J; Hausleiter J; Dirschinger J; Dotzer F; Bollwein H; Schömig A
    Am Heart J; 2006 Jun; 151(6):1248-54. PubMed ID: 16781230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting.
    Kopp CW; Steiner S; Nasel C; Seidinger D; Mlekusch I; Lang W; Bartok A; Ahmadi R; Minar E
    Stroke; 2003 Nov; 34(11):2560-7. PubMed ID: 14563968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute intraprocedural thrombus formation during wingspan intracranial stent placement for intracranial atherosclerotic disease.
    Lawson MF; Fautheree GL; Waters MF; Decker DA; Mocco JD; Hoh BL
    Neurosurgery; 2010 Sep; 67(3 Suppl Operative):ons166-70; discussion ons170. PubMed ID: 20679932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Rescue platelet glycoprotein IIb/IIIa inhibitor therapy in thrombosis complicating superficial femoral artery angioplasty.
    Grollman JH; Coil A
    Cardiovasc Intervent Radiol; 2002; 25(1):77-80. PubMed ID: 11907783
    [No Abstract]   [Full Text] [Related]  

  • 16. Will blocking the platelet save the diabetic?
    King SB; Mahmud E
    Circulation; 1999 Dec 21-28; 100(25):2466-8. PubMed ID: 10604881
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).
    Islam MA; Blankenship JC; Balog C; Iliadis EA; Lincoff AM; Tcheng JE; Califf RM; Topol EJ;
    Am J Cardiol; 2002 Nov; 90(9):916-21. PubMed ID: 12398954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis.
    Berkompas DC
    Cathet Cardiovasc Diagn; 1998 Nov; 45(3):272-4. PubMed ID: 9829886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Images in cardiovascular medicine. IIb/IIIa receptor antagonists for failed rescue angioplasty.
    Ronner E; van der Wieken LR; Slagboom TS; Laarman GJ; Kiemeneij F
    Circulation; 2000 Jan; 101(2):214-5. PubMed ID: 10637211
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation.
    Henry P; Boughalem K; Rinaldi JP; Makowski S; Khalife K; Guermonprez JL; Blanchard D
    Cathet Cardiovasc Diagn; 1998 Jan; 43(1):105-7. PubMed ID: 9473205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.